Waldencast plc (NASDAQ: WALD) (“Waldencast” or “the Company”) today announced that it has entered into a definitive agreement to sell its Obagi Medical dermatological skincare and aesthetics business ...
Fashionista on MSN
Must read: Target's fashion revival strategy, Bridgepoint Group to acquire Obagi Medical
Plus, Friends of the CFDA names new chair.
Add Yahoo as a preferred source to see more of our stories on Google. PARIS — Bridgepoint is set to acquire RoC Skincare, the French dermatological brand launched in 1957. The undisclosed investment ...
Mid-market investor Bridgepoint has agreed to buy Waldencast's Obagi Medical dermatological skincare and aesthetics business in a deal with an enterprise value of up to $460 million.
Bridgepoint Group Plc is set to raise about €5 billion ($5.8 billion) to target financing opportunities in Europe’s direct lending market, people with knowledge of the matter said.
‘The market has come towards the sellers, but the sellers have also now agreed to reduce their expectations,’ the Bridgepoint chief investment officer told PE Hub in this NEXUS 2025 preview interview.
The Consumer Financial Protection Bureau (CFBP) took action on Monday against Ashford University and the University of the Rockies, two for-profit colleges operated by Bridgepoint Education Inc (NYSE: ...
In recent months, the UK market has faced challenges as the FTSE 100 index experienced declines due to weak trade data from China, impacting companies closely tied to its economic performance. Amid ...
Bridgepoint is a private asset growth investor with over $40bn of assets under management The upfront enterprise value is £835 million ECP addition will add to Bridgepoint’s private equity and private ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results